Magazine Article | January 4, 2022

Tackling Uncertainty In Drug R&D

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Is it quantum effects, evolutionary quirks, or ordinary human imperfection that renders discovery and development of new drugs and the prediction of their effects so uncertain? Uncertainty is manifested in the infinitesimal success rate of new drug development in general. Most new drug entities in R&D either fail to achieve approval or deliver far less than perfect results — often perhaps because their targets and mechanisms are products of engineering based on inaccurate mathematical models. The practice has spawned a new field and probably cutting-edge discipline for biopharma developers: bioinformatics.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: